Oclacitinib is a Janus kinase (JAK) 1 enzyme inhibitor and blocks JAK1-dependent cytokines, such as IL-2, IL-4, IL-6, IL-13, and IL-31 involved in allergy, inflammation, and pruritus [11]. Here, IL31 is linked to Pruritus.